CAR T-Cell Therapy Continues to Spark Interest for Treatment of Patients With DLBCL
In an interview with Targeted Oncology, Nilanjan Ghosh, MD, discussed the current challenges in using CAR T-cell therapy as treatment of patients with DLBCL and considers the next steps for this research.